Press Release Nicox: 2024 Ordinary Shareholder MeetingJune 27, 2024 – release at 17:30 CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, ALCOX), an international ophthalmology...
Nicox SA Société anonyme with a registered capital of 502,996.94 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois – 06410 BiotR.C.S. ANTIBES 403.942.642 On June 3rd,...
Press Release Nicox's Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 Shareholders adopted all resolutions proposed by the Board of Directors at the Ordinary and Extraordinary General...
Nicox SA Soci©t© anonyme with a registered capital of ‚ 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois “ 06410 BiotR.C.S. ANTIBES 403.942.642 On May 2nd,...
Press Release Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentApril 24, 2024 “ release at 07:30 CET Sophia Antipolis,...
Press Release Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial Results Nicox Group revenue of ‚4.4 million (net revenue1 ‚3.9 million) for first quarter 2024Nicox Group cash of...
Dear Shareholder, The upcoming Extraordinary General Meeting, which will take place on April 10, is of particular importance for Nicox. I am writing to you today, in my capacity as the new Chief...
Nicox Updates on Corporate, Pipeline and Financing Perspectives
Nicox Announces Presentation of Data on NCX 470
Number of voting rights as of February 29, 2024